1. Home
  2. WST vs BBD Comparison

WST vs BBD Comparison

Compare WST & BBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • BBD
  • Stock Information
  • Founded
  • WST 1923
  • BBD 1943
  • Country
  • WST United States
  • BBD Brazil
  • Employees
  • WST N/A
  • BBD N/A
  • Industry
  • WST Medical/Dental Instruments
  • BBD Major Banks
  • Sector
  • WST Health Care
  • BBD Finance
  • Exchange
  • WST Nasdaq
  • BBD Nasdaq
  • Market Cap
  • WST 20.1B
  • BBD 30.6B
  • IPO Year
  • WST N/A
  • BBD N/A
  • Fundamental
  • Price
  • WST $283.49
  • BBD $3.39
  • Analyst Decision
  • WST Strong Buy
  • BBD Strong Buy
  • Analyst Count
  • WST 8
  • BBD 4
  • Target Price
  • WST $355.14
  • BBD $2.55
  • AVG Volume (30 Days)
  • WST 740.0K
  • BBD 63.0M
  • Earning Date
  • WST 10-23-2025
  • BBD 10-29-2025
  • Dividend Yield
  • WST 0.31%
  • BBD 4.88%
  • EPS Growth
  • WST 0.17
  • BBD 58.81
  • EPS
  • WST 6.75
  • BBD 0.36
  • Revenue
  • WST $3,017,900,000.00
  • BBD $16,114,445,927.00
  • Revenue This Year
  • WST $6.49
  • BBD $77.46
  • Revenue Next Year
  • WST $6.23
  • BBD $7.42
  • P/E Ratio
  • WST $41.99
  • BBD $8.79
  • Revenue Growth
  • WST 4.92
  • BBD 27.09
  • 52 Week Low
  • WST $187.43
  • BBD $1.84
  • 52 Week High
  • WST $348.90
  • BBD $3.42
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.19
  • BBD 61.81
  • Support Level
  • WST $260.12
  • BBD $3.28
  • Resistance Level
  • WST $322.34
  • BBD $3.39
  • Average True Range (ATR)
  • WST 8.49
  • BBD 0.07
  • MACD
  • WST 1.73
  • BBD 0.01
  • Stochastic Oscillator
  • WST 40.08
  • BBD 92.11

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About BBD Banco Bradesco Sa

Banco Bradesco is Brazil's second-largest private bank, with about 10%-15% of deposits, and the largest insurance provider in Brazil, with roughly 20%-25% market share. The bank is majority controlled by the Bradesco foundation—a private nonprofit institution focused on education. The bank is also a major asset manager with high-single-digit market share. In 2016, Bradesco acquired the Brazilian operations of HSBC.

Share on Social Networks: